Year: 2026
Type: article
Abstract: Background The association between baseline random blood glucose (RBG) and subsequent autoimmune hepatitis (AIH), and its relationship with systemic inflammation, remain unclear. Method The original UK Biobank analysis included 425,489 participants with 284 AIH records. After exclusion of two participants with AIH recorded on or before baseline, the prospective analyses included 425,487 participants and 282 incident hospital-recorded AIH events. A small hospital-based case-control sample from the Affiliated Hospital of Qingdao University, comprising 23 AIH cases and nine controls, provided supplementary descriptive information and exploratory analyses and was not used for external validation. Logistic regression, Cox regression, and two-year landmark analyses were used to examine the associations with AIH. Restricted cubic spline, exploratory threshold, subgroup, ROC, and mediation analyses were also performed. The jointly adjusted Cox model included age, sex, ethnicity, Townsend deprivation index, educational attainment, smoking status, and alcohol consumption. Result In the jointly adjusted baseline Cox model, each 1 mmol/L higher RBG was associated with an HR of 1.096 (95% CI, 1.023-1.176; P = 0.0095), whereas the highest-versus-lowest quartile comparison was not statistically significant (HR, 1.315; 95% CI, 0.945-1.831; P = 0.1046). In the two-year landmark analysis, the corresponding HRs were 1.115 (95% CI, 1.042-1.193; P = 0.0016) and 1.549 (95% CI, 1.080-2.222; P = 0.0175). RBG alone showed limited discrimination (AUC, 0.531; 95% CI, 0.496-0.566). Conclusion Higher baseline RBG was modestly associated with subsequent hospital-recorded AIH, although quartile comparisons differed between baseline and landmark analyses. These exploratory findings do not establish causality or a clinically actionable glucose threshold. The limited discrimination of RBG does not support its use as a standalone screening marker for AIH.
Source: Frontiers in Immunology
Language: English
Topic: Liver Diseases and Immunity
Subfield: Hepatology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $3,801
OpenAlex ID: W7235128893
